Skip to main content
. 2022 Apr 22;112(12):1715–1726. doi: 10.1007/s00392-022-02020-3

Table 2.

Provocation strategy of Brugada phenotype

Provocation strategy of Brugada phenotype
Augmentation of arrhythmogenic substrate 316/388 (81%)a
Sodium channel blocker n=309
    Ajmaline 235 (76%)
    Pilsicainide 36 (12%)
    Flecainide 20 (6%)
    Propafenone 10 (3%)
    Procainamide 8 (3%)
Other strategy n=9
Epicardial warmed (39–40 ℃) 0.9% saline instillation 9 (100%)

aTwo patients were used both sodium channel blocker and epicardial warm water instillation